Press Releases

• Q4 net sales 3.2%; organic sales1 1.2% • Q4 diluted EPS was $0.17; adjusted diluted EPS1 was $0.27 • FY’25 net sales (2.1)%; organic sales (2.2)% • FY’25 diluted EPS was $0.76;...

SUMMIT, N.J., February 4, 2026 - Kenvue Inc. (NYSE: KVUE) will announce its fourth quarter and full year 2025 financial results after market close on February 17, 2026. Due to the pending...

SUMMIT, N.J., January 28, 2026 - Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.2075 per share on its common stock. The quarterly dividend...

2025 results show further momentum from Powering Care strategy, supporting further strategic transformation 2026 outlook reflects continued organic growth and operating momentum as transformation...

Kenvue Brands LLC, the maker of Tylenol®, issued the following statement in response to today’s filing by the Office of the Attorney General of Texas: We are taking immediate legal action to...

• Net sales (3.5)%; organic sales1 (4.4)% • Diluted EPS was $0.21; adjusted diluted EPS1 was $0.28 • Affirms outlook for FY’25 • Kirk Perry named permanent Chief Executive Officer and...

SUMMIT, N.J., October 29, 2025 - Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.2075 per share on its common stock. The quarterly dividend...

SUMMIT, N.J., October 27, 2025 - Kenvue Inc. (NYSE: KVUE) will announce its third quarter 2025 financial results before the market opens on November 6, 2025. The company will host a conference...

• One in five nicotine users start by using products such as electronic cigarettes or nicotine pouches1 • Campaign calls on policymakers to regulate all tobacco and nicotine products, support...

We sympathize deeply with people living with cancer. We understand that they and their families want answers—that’s why the facts are so important. The safety of JOHNSON’S® Baby Powder is...

Kimberly-Clark Corporation (NASDAQ: KMB) is deepening its commitment to advancing essential care for women and girls through four enhanced strategic, charitable partnerships. Through new programs with

Kimberly-Clark Corporation (NASDAQ: KMB) today announced the appointment of Stacey Valy Panayiotou to Chief Human Resources Officer, effective September 10th. Panayiotou will succeed interim Chief...

- Study underscores shift toward viewing personal care as a tool for overall well-being as well as appearance - Trusted vs. go-to sources for personal care advice are not always the same -...

Kimberly-Clark Corporation (NASDAQ: KMB) today announced the appointment of John Carmichael as President, North America, effective September 15th. Carmichael succeeds interim President Kurt...

• Net sales (4.0)%; organic sales1 (4.2)% • Diluted EPS was $0.22; adjusted diluted EPS1 was $0.29 • Continues to advance ongoing review of strategic alternatives, while taking actions to...

SUMMIT, N.J., July 30, 2025 – Kenvue Inc. (NYSE: KVUE) today announced its Board of Directors declared a quarterly dividend of $0.2075 per share on its common stock, which represents a 1.2...

Kimberly-Clark Corporation (NYSE: KMB), a global leader in the consumer staples industry, announced today that it will voluntarily transfer its U.S. stock exchange listing to the Nasdaq Global...

Kimberly-Clark Corporation (NYSE: KMB) today announced that Russ Torres, President, North America, has been promoted to President and Chief Operating Officer, effective immediately. As President...

Kimberly-Clark Corporation (NYSE: KMB) today announced plans to invest over $2 billion over the next 5 years in its North America business, marking the company's largest domestic expansion in more...

Kenvue Brands LLC, the maker of Tylenol®, issued the following statement in response to scientifically unfounded litigation filed by the Office of the Attorney General of Texas. What Matters Most...

Kimberly-Clark Corporation (NYSE: KMB) today announced that Joseph Romanelli, president of Human Health International for Merck & Co., Inc., Rahway, NJ, USA, ("MSD") has been elected to its board...

Kimberly-Clark (NYSE: KMB) will issue its third quarter 2024 results on Tuesday, October 22. A press release and supplemental materials will be issued at approximately 6:35 a.m. EDT....

SKILLMAN, N.J., Aug. 15, 2024 — Kenvue Inc. (NYSE: KVUE) (“Kenvue” or the “Company”), the world’s largest pure-play consumer health company by revenue, is launching Neutrogena®1...

The board of directors of Kimberly-Clark Corporation (NYSE: KMB) has declared a regular quarterly dividend of $1.22 per share. The dividend is payable in cash on October 2, 2024, to stockholders...

Delivers net sales of $5.0 billion driven by 4 percent organic sales growth Strong EPS expansion driven by innovation-led volume gains, effective cost management and productivity Company increases...